IL22 and colitis: TL1A promotes group 3 innate lymphoid cells to produce IL-22 which can protect acute colitis by promoting mucosal healing [127]; furthermore, TL1A induces OX40L expression on group 3 innate lymphoid cells which stimulates T cell activation and is required for T cell-driven murine colitis [127].